PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Scientists reverse Alzheimer’s in mice using nanoparticles

The innovative approach to treating the disease focuses on restoring the normal function of the vasculature, rather than acting on neurons or other brain cells, as has usually been done until now.

2025-10-07
(Press-News.org)

A research team co-led by the Institute for Bioengineering of Catalonia (IBEC) and West China Hospital Sichuan University (WCHSU), working with partners in the UK, has demonstrated a nanotechnology strategy that reverses Alzheimer’s disease in mice. Unlike traditional nanomedicine, which relies on nanoparticles as carriers for therapeutic molecules, this approach employs nanoparticles that are bioactive in their own right: “supramolecular drugs.” Instead of targeting neurons directly, the therapy restores the proper function of the blood-brain barrier (BBB), the vascular gatekeeper that regulates the brain’s environment. By repairing this critical interface, the researchers achieved a reversal of Alzheimer’s pathology in animal models.

The brain is the most expensive organ of the body, consuming 20% of the energy in adults and up to 60% in children. This energy arrives through a vast blood supply, assured by a unique and dense vascular system where each neuron is nourished by one capillary. Our brain contains approximately one billion capillaries, highlighting the vital role of brain vasculature in maintaining health and combating disease. These findings highlight the crucial role of vascular health, especially in diseases like dementia and Alzheimer’s, where a compromised vascular system is closely linked.

The BBB is a cellular and physiological barrier that separates the brain from the blood flow to protect it from external dangers such as pathogens or toxins. The team demonstrated that targeting a specific mechanism enables undesirable “waste proteins” produced in the brain to pass through this barrier and be eliminated in the blood flow. In Alzheimer’s disease, the main “waste” protein is amyloid-β (Aβ), whose accumulation impairs the normal functioning of the neurons.

Researchers used mouse models that are genetically programmed to produce larger amounts of Aβ protein and develop a significant cognitive decline mimicking Alzheimer’s pathology. They administered only 3 doses of the supramolecular drugs and afterwards regularly monitored the evolution of the disease. “Only 1h after the injection we observed a reduction of 50-60% in Aβ amount inside the brain” explains Junyang Chen, first co-author of the study, researcher at the West China Hospital of Sichuan University and PhD student at the University College London (UCL).

The most striking data were the therapeutic effects. Researchers conducted various experiments to analyze the behavior of the animals and measure their memory decline over several months, covering all stages of the disease. In one of the experiments, they treated a 12-month-old mouse (equivalent to a 60-year-old human) with the nanoparticles and analysed its behaviour after 6 months. The result was impressive: the animal, aged 18 months (comparable to a 90-year-old human), had recovered the behaviour of a healthy mouse.

“The long-term effect comes from restoring the brain’s vasculature. We think it works like a cascade: when toxic species such as amyloid-beta (Aβ) accumulate, disease progresses. But once the vasculature is able to function again, it starts clearing Aβ and other harmful molecules, allowing the whole system to recover its balance. What’s remarkable is that our nanoparticles act as a drug and seem to activate a feedback mechanism that brings this clearance pathway back to normal levels.”

Giuseppe Battaglia, ICREA Research Professor at IBEC, Principal Investigator of the Molecular Bionics Group and leader of the study.

 

Amyloid-β clearance from the brain

In Alzheimer’s disease, one of the key problems is that the brain’s natural clearance system for toxic species like amyloid-β stops working properly. Normally, the protein LRP1 acts as a molecular gatekeeper: it recognizes Aβ, binds to it through ligands, and ferries it across the blood-brain barrier into the bloodstream, where it can be removed. But this system is fragile. If LRP1 binds too much Aβ too tightly, the transport clogs and the protein itself gets degraded inside the brain barrier cells, leaving fewer LRP1 “carriers” available. On the other hand, if it binds too little, the signal is too weak to trigger transport. In both cases, the result is the same: Aβ builds up inside the brain.

The supramolecular drugs developed in this work act like a switch that resets the system. By mimicking the ligands of LRP1, they can bind to Aβ, cross the blood–brain barrier, and initiate the process of removing toxic species from the brain. In doing so, they help restore the vasculature’s natural role as a waste-clearing pathway and bring it back to proper function.

 

Nanoparticles to treat Alzheimer’s

In this study, the researchers introduce nanoparticles that act as supramolecular drugs, therapeutic agents in their own right rather than carriers of medication. Designed with a bottom-up molecular engineering approach, these nanoparticles combine precise size control with a defined number of surface ligands, creating a multivalent platform able to interact with cellular receptors in a highly specific way. By engaging receptor trafficking at the cell membrane, they open up a unique and novel way to modulate receptor function. This precision not only enables the effective clearance of amyloid-β from the brain but also restores balance to the vascular system that maintains healthy brain function.

This innovative therapeutic paradigm offers a promising pathway for developing effective clinical interventions, addressing vascular contributions to Alzheimer’s disease, and ultimately enhancing patient outcomes. “Our study demonstrated remarkable efficacy in achieving rapid Aβ clearance, restoring healthy function in the blood–brain barrier and leading to a striking reversal of Alzheimer’s pathology.”, concludes Lorena Ruiz Perez, researcher at the Molecular Bionics group from the Institute for Bioengineering of Catalonia (IBEC) and Serra Hunter Assistant Professor at the University of Barcelona (UB).

The study was a collaboration among the Institute for Bioengineering of Catalunya (IBEC), West China Hospital of Sichuan University, West China Xiamen Hospital of Sichuan University, University College London, the Xiamen Key Laboratory of Psychoradiology and Neuromodulation, University of Barcelona,Chinese Academy of Medical Sciences and the Catalan Institution for Research and Advanced Studies (ICREA).

About IBEC

The Institute for Bioengineering of Catalonia (IBEC) is a CERCA center, three times recognized as a Severo Ochoa Center of Excellence, and holds the TECNIO label as a technology developer and business facilitator. IBEC is a member of the Barcelona Institute of Science and Technology (BIST) and conducts multidisciplinary research at the forefront of engineering and life sciences to generate knowledge. The institute integrates fields such as nanomedicine, biophysics, biotechnology, tissue engineering, and applications of information technologies in the health sector. IBEC, established in 2005, is a collaborative effort of the Generalitat de Catalunya, the University of Barcelona (UB), and the Polytechnic University of Catalonia (UPC).

END



ELSE PRESS RELEASES FROM THIS DATE:

‘Good’ gut bacteria boosts placenta for healthier pregnancy

2025-10-07
Research led by the University of Cambridge has found the first clear evidence that the ‘good’ gut bacteria Bifidobacterium breve in pregnant mothers regulates the placenta’s production of hormones critical for a healthy pregnancy. In a study in mice, the researchers compared the placentas of mice with no gut bacteria to those of mice with Bifidobacterium breve in their gut during pregnancy. Pregnant mice without Bifidobacterium breve in their gut had a higher rate of complications including fetal growth restriction and fetal low blood sugar, and increased fetal loss. This gut bacteria seems to play a crucial role in prompting the placenta ...

USC team demonstrates first optical device based on “optical thermodynamics”

2025-10-06
A team of researchers at the Ming Hsieh Department of Electrical and Computer Engineering has created a new breakthrough in photonics: the design of the first optical device that follows the emerging framework of optical thermodynamics. The work, reported in Nature Photonics, introduces a fundamentally new way of routing light in nonlinear systems—meaning systems that do not require switches, external control, or digital addressing. Instead, light naturally finds its way through the device, guided by simple thermodynamic principles. From Valves to Routers to Light Universal routing is a familiar engineering ...

Microplastics found to change gut microbiome in first human-sample study

2025-10-06
Microplastics found to change gut microbiome in first human-sample study  (Berlin, Germany, Tuesday, 7 October 2025) New research presented today at UEG Week 2025 shows that microplastics – plastic particles smaller than 5mm commonly found in the environment – can alter the human gut microbiome, with some changes resembling patterns linked to depression and colorectal cancer.1 This study, conducted within the framework of microONE, a pioneering COMET Module programme project led by CBmed research center in collaboration with international partners, is among the first ...

Artificially sweetened and sugary drinks are both associated with an increased risk of liver disease, study finds

2025-10-06
Artificially sweetened and sugary drinks are both associated with an increased risk of liver disease, study finds (Berlin, Germany, Tuesday, 7 October 2025) A major new study reveals that both sugar-sweetened beverages (SSBs) and low- or non-sugar-sweetened beverages (LNSSBs) are significantly associated with a higher risk of developing metabolic dysfunction-associated steatotic liver disease (MASLD).1 The study, presented today at UEG Week 2025, followed 123,788 UK Biobank participants without liver disease at baseline. Beverage consumption was assessed using repeated ...

Plastic in the soil, but not as we know it: Biodegradable microplastics rewire carbon storage in farm fields

2025-10-06
We often think of plastic pollution as a problem of oceans and seabirds. But beneath our feet, in the quiet dark of agricultural soils, a new kind of contamination is unfolding—one with profound implications for climate, crops, and carbon. A pioneering two-year field study has revealed that biodegradable microplastics, often hailed as eco-friendly alternatives to conventional plastics, are quietly reshaping the chemistry of farmland soils in unexpected and complex ways. Published on August 22, 2025, in Carbon Research as an open-access original article, this research was co-led by Dr. Jie ...

Yeast proteins reveal the secrets of drought resistance

2025-10-06
Our bodies are made up mostly of water. If this water is removed, our cells cannot survive, even when water is reintroduced. But some organisms can completely dry out yet return to life when rehydrated. A new study in Cell Systems helps explain how organisms can come back from desiccation (the removal of water or moisture) while others fail by looking at the cell’s proteins. In the first survey of its kind, a team of researchers profiled thousands of proteins at once for their ability to survive dehydration and ...

Psychiatry, primary care, and OB/GYN subspecialties hit hardest by physician attrition

2025-10-06
Embargoed for release until 5:00 p.m. ET on Monday 6 October 2025    Follow @Annalsofim on X, Facebook, Instagram, Bluesky, and Linkedin              Below please find summaries of new articles that will be published in the next issue of Annals of Internal Medicine. The summaries are not intended to substitute for the full articles as a source of information. This information is under strict embargo and by taking it into possession, media representatives are committing to the terms of the embargo not only on their own behalf, ...

New Canadian study reveals where HIV hides in different parts of the body

2025-10-06
New Canadian study reveals where HIV hides in different parts of the body Researchers at Western University and the University of Calgary have discovered how HIV hides in different parts of the body by embedding itself into the DNA of cells in a tissue-specific manner, offering new insights into why the virus is so difficult to eliminate and cure – even decades after infection and treatment. The study, led by Western University’s Stephen Barr and UCalgary’s Guido van Marle, reveals that HIV cloaks itself in the DNA of infected cells using unique DNA patterns in the ...

Lidocaine poisonings rise despite overall drop in local anesthetic toxicity

2025-10-06
Over the last decade, poisonings and deaths linked to the use of local anesthetics have decreased. Even so, poisonings from one commonly used anesthetic, lidocaine, have increased in the United States, according to two new studies from the University of Illinois Chicago. By analyzing data from reports to national Poison Control Centers and to the Food and Drug Administration from 2010 to 2020, UIC researchers found total reports of poisonings fell 50% in that period. But poisonings from lidocaine increased more than 50% in less than half that ...

Politics follow you on the road

2025-10-06
Nobody wants to admit that a lowly bumper sticker can influence their behavior. But researchers at the University of Cincinnati found that drivers were far more likely to honk after being cut off by a vehicle bearing a political bumper sticker, particularly one for the opposing political party. “Bumper stickers are a meaningful way in which partisan divides are reinforced in everyday life,” UC researchers concluded. “They have tangible impacts on road safety. Partisan bumper stickers may be mundane, but they are not trivial.” For a study published in the journal Frontiers in Political Science, UC Assistant ...

LAST 30 PRESS RELEASES:

Scientists reverse Alzheimer’s in mice using nanoparticles

‘Good’ gut bacteria boosts placenta for healthier pregnancy

USC team demonstrates first optical device based on “optical thermodynamics”

Microplastics found to change gut microbiome in first human-sample study

Artificially sweetened and sugary drinks are both associated with an increased risk of liver disease, study finds

Plastic in the soil, but not as we know it: Biodegradable microplastics rewire carbon storage in farm fields

Yeast proteins reveal the secrets of drought resistance

Psychiatry, primary care, and OB/GYN subspecialties hit hardest by physician attrition

New Canadian study reveals where HIV hides in different parts of the body

Lidocaine poisonings rise despite overall drop in local anesthetic toxicity

Politics follow you on the road

Scientists blaze new path to fighting viral diseases

The mouse eye as a window to spotting systemic disease

AI and the Future of Cancer Research and Cancer Care to headline October 24 gathering of global oncology leaders at the National Press Club: NFCR Global Summit to feature top scientists, entrepreneurs

FDA clears UCLA heart tissue regeneration drug AD-NP1 for clinical trials

Exploring the therapeutic potential of cannabidiol for Alzheimer's

We need a solar sail probe to detect space tornadoes earlier, more accurately, U-M researchers say

Acute myeloid leukemia (AML): Disease risk but not remission status determines transplant outcomes – new ASAP long-term results

Sperm microRNAs: Key regulators of the paternal transmission of exercise capacity

Seeing double: Clever images open doors for brain research

Inhaler-related greenhouse gas emissions in the US

UCLA Health study finds inhalers for asthma and COPD drive significant greenhouse gas emissions

A surgical handover system for patient physiology and safety

Cardiovascular health changes in young adults and risk of later-life cardiovascular disease

Nurse workload and missed nursing care in neonatal intensive care units

How to solve the remote work stalemate – dissertation offers tools for successful hybrid work

Chip-based phonon splitter brings hybrid quantum networks closer to reality

Texas Children’s researchers create groundbreaking tool to improve accuracy of genetic testing

Milken Institute, Ann Theodore Foundation announce more than $2.5 million in new funding for sarcoidosis research and launch new call for proposals

Boston University professor to receive 2025 Eugene Braunwald Academic Mentorship Award

[Press-News.org] Scientists reverse Alzheimer’s in mice using nanoparticles
The innovative approach to treating the disease focuses on restoring the normal function of the vasculature, rather than acting on neurons or other brain cells, as has usually been done until now.